Id |
Subject |
Object |
Predicate |
Lexical cue |
T202 |
0-109 |
Sentence |
denotes |
Table 3 Lactoferrin sources as supplements, and examples where it has been used to treat various conditions. |
T203 |
110-144 |
Sentence |
denotes |
Lactoferrin sources as supplements |
T204 |
145-165 |
Sentence |
denotes |
Product References |
T205 |
166-310 |
Sentence |
denotes |
Bovine and human milk Morinaga Industries in Japan (183) DoMO Food Ingredients, a subsidiary of Friesland Dairy Foods, in the Netherlands (184) |
T206 |
311-401 |
Sentence |
denotes |
Human recombinant lactoferrin Talactoferrin from Agennix, Inc., Houston, Texas, USA (184) |
T207 |
402-500 |
Sentence |
denotes |
Lactoferrin expression in transgenic rice Ventrus Biosciences, New York City, New York, USA (184) |
T208 |
501-559 |
Sentence |
denotes |
Transgenic cattle expressing human lactoferrin (185, 186) |
T209 |
560-631 |
Sentence |
denotes |
Transgenic maize Meristem therapeutics, Clermont-Ferrand, France (184) |
T210 |
632-692 |
Sentence |
denotes |
Lactoferrin supplementation in treatment of various diseases |
T211 |
693-783 |
Sentence |
denotes |
Might be useful in treating sepsis or necrotizing enterocolitis in preterm neonates (184) |
T212 |
784-817 |
Sentence |
denotes |
Support for vaginal health (187) |
T213 |
818-1015 |
Sentence |
denotes |
LF may play a protective role in host defense against SARS-CoV infection through binding to HSPGs and blocking the preliminary interaction between SARS-CoV and host cells (cell culture study) (99) |
T214 |
1016-1189 |
Sentence |
denotes |
LF is a modulator of innate immune responses in the urinary tract and has potential application in novel therapeutic design for urinary tract infection (animal study) (188) |
T215 |
1190-1272 |
Sentence |
denotes |
Possible therapy against Candida albicans in the oral cavity (a hypothesis) (189) |
T216 |
1273-1341 |
Sentence |
denotes |
Protection against Chlamydia trachomatis (cell culture study) (190) |
T217 |
1342-1409 |
Sentence |
denotes |
Treatment of taste and smell abnormalities after chemotherapy (52) |
T218 |
1410-1483 |
Sentence |
denotes |
LF supplements and food with high levels of LF for oral health (99, 191) |
T219 |
1484-1580 |
Sentence |
denotes |
LF treatment of black stain associated with of iron metabolism disorders with lactoferrin (192) |
T220 |
1581-1747 |
Sentence |
denotes |
Aerosolized bovine LF counteracts infection, inflammation and iron dysbalance in a cystic fibrosis mouse model of Pseudomonas aeruginosa chronic lung infection (193) |
T221 |
1748-1785 |
Sentence |
denotes |
LF inhalations for lung health (194) |
T222 |
1786-1821 |
Sentence |
denotes |
LF for optimal skin moisture (195) |